Search Articles — Sudonull

https://sudonull.com/claude-mythos-leak-and-cyber-power-of-anthropic

Anthropic leaked data about Claude Mythos — top model focused on cybersecurity. Comparison with Opus, attack risks, and limited release. Read details for developers.

https://sudonull.com/ai-agent-for-technical-specification-verification-development-architecture-practice

Practical experience creating an AI-agent for auditing technical specifications. Learn about data collection, error classification, and hybrid RAG + decision trees architecture.

https://sudonull.com/dragon-test-of-rag-systems-on-dynamic-data

Learn about DRAGOn — an open methodology for testing Russian-language RAG. Dynamic corpora, logical tasks, leaderboard. Deploy tests on your own data for senior developers.

https://sudonull.com/git-log-analysis-hidden-data-on-team-and-project-metrics

Learn how to extract insights about developers and the project from Git logs. Methods for analyzing email, commits, and tasks for technical specialists.

https://sudonull.com/ai-data-centers-heat-the-environment-by-9-1-c-facts

AI Data Centers Raise Temperature by 2–9.1 °C Within 10 km Radius, Affecting 340 Million People. Cambridge Study: Data, Methodology, Forecasts. Learn About the Impact on Climate

https://ymaho.com/study-of-the-ottava-robot-forte-results-and-fda-application

Scientists have completed the pivotal study of the Ottava robot (FORTE) and are preparing an FDA application. Learn about clinical data, zero conversions, and market prospects for robotic surgery.

https://ymaho.com/targeted-therapy-for-usher-syndrome-1b-new-data-on-aavb-081

Interim data from phase 1/2 gene therapy AAVB-081 for Usher syndrome 1B: safety, efficacy, and prognosis. Learn about the dual AAV vector and treatment prospects.

https://lrivo.com/arsenal-s-april-struggles-what-the-data-shows

Explore the historical data on Arsenal's April performances and why it's a cause for concern. Learn about the upcoming challenges and how they compare to Manchester City.

https://ymaho.com/paricalcitol-in-metastatic-cancer-2026-data

2026 clinical data confirmed the safety of the vitamin D analog paricalcitol in metastatic pancreatic cancer. Learn about the mechanism, results, and limitations.

https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough

Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.

https://ymaho.com/moon-heat-discovery-challenges-old-theories

New data from Blue Ghost lander shows unexpected lunar heat — reshaping what we know about the moon's geology. Learn why it matters.

https://ymaho.com/robotic-liver-transplantation-safety-and-innovations

Data analysis of robotic liver transplantation: 0.3% complications, accelerated learning, and a new donor selection standard. Learn more about the technology.

https://ymaho.com/car-t-therapy-hiv-years-of-remission-after-infusion

DUET-2 data: CAR-T cells keep HIV in remission for over 2 years without ART. Functional cure already a reality? Learn about the breakthrough in HIV treatment.

https://ymaho.com/crispr-therapy-verve-102-reduces-cholesterol-by-62-after-injection

Journal NEJM published data on the drug VERVE-102: a single CRISPR injection (base editing) reduces LDL by 62% for 18 months without serious side effects. Learn details about the revolutionary therapy.

https://ymaho.com/rna-editing-breakthrough-in-nature-and-a-new-class-of-drugs

Breakthrough in RNA Editing: Nature Data on Cas13b-ADAR2 and the MIRROR System. The RNA Therapy Market Is Growing. Read About the New Class of Drugs and Treatment Prospects.